
Product Insights
Defumoxan is an oral tablet marketed by Aflofarm to support the treatment of nicotine dependence, delivering 1.5 mg of the active ingredient citizin per tablet. It provides a standardized dose that can help smokers gradually reduce cravings while being easy to administer. However, the product may contain traces of lamb meat, lists no specific excipients, and lacks comprehensive allergen or safety labeling, which could pose concerns for vegans, individuals with meat allergies, or those requiring full ingredient transparency.
Comparative Analysis
Defumoxan targets the nicotine-cessation segment as a low-dose citizin tablet (1.5 mg per dose) for oral use, positioning itself as a straightforward pharmacological aid distinct from nicotine patches or gums, while noting its possible lamb-derived excipients.
Ingredients
Tratamentul dependenţei de nicotină. Fiecare comprimat conţine citizină 1,5 mg. Administrare orală. A se citi prospectul înainte de utilizare. Poate conține carne de miel
Unlock Full Product Insights
Scan this and millions of other daily products to reveal hidden ingredients, safety alerts, and comprehensive analysis with the free NutrScan app.
Frequently Asked Questions
Everything you need to know about defumoxan.








